MedTrace Logo

Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)

NCT07246915 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2025-11-24

No results posted yet for this study

Summary

A non-interventional, extension study on the long-term maintenance of safety and performance of the REVISYON SDS 100 medical device in subjects with mild-to-moderate cataract.

Conditions

  • Age-related Cataract
  • Vision Loss
  • Cataract
  • Mild Cataract
  • Moderate Cataract

Sponsors & Collaborators

  • MDX Research

    collaborator NETWORK

  • Edinburgh Biosciences Ltd

    lead INDUSTRY

Principal Investigators

  • Trevor Shields · Edinburgh Biosciences

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-28
Primary Completion
2025-12-15
Completion
2025-12-15

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07246915 on ClinicalTrials.gov